Skip to main content

VHCAX

ETF

VHCAX

ETF
—
—

Performance overview

VHCAX Price
Price Chart

Forward-looking statistics

Beta
1.05
Risk
19.25%

Detailed forecast

[disclaimer]

Individual forecast components (weighted-sum)

Fund Profile

—

Fund info

—

Investing methodUnknown
DiversifiedNo
Expense ratio0.36%
Asset classEquities

Top holdings

Eli Lilly and Co9.56%
Amgen Inc2.94%
Biogen Inc2.90%
Seagen Inc Ordinary Shares2.61%
Biomarin Pharmaceutical Inc2.45%
Microsoft Corp2.28%
FedEx Corp2.25%
Flex Ltd2.09%
Splunk Inc2.05%
Other70.87%

Sector exposure

Health Care33.96%
Information Technology27.96%
Industrials11.48%
Consumer Discretionary9.86%
Financials6.79%
Communication Services5.58%
Energy3.77%
Materials0.43%
Consumer Staples0.18%
Other-0.01%

Country exposure

United States99.21%
Mexico0.21%
United Kingdom0.12%
China0.04%
Other0.42%

Company info

Sector—
Industry—
Website—
AUM—

Security info

ExchangeNASDAQ
Type of shareN/A
Earnings per share (EPS)—
Dividend per share—
Revenue per share—
Avg trading volume (30 day)—
Avg trading volume (10 day)—
Put-call ratioN/A

Macro factor sensitivity

Growth+1.1
Credit+2.9
Liquidity-0.1
Inflation-2.0
Commodities+0.1
Interest Rates-1.2

Upcoming events

Next earnings day—
Next dividend day—
Ex. dividend day—

Unlock Personalized Financial Tools

All our core financial tools are completely free. Create an account to save your research, get personalized recommendations, and enjoy unlimited access.

Save research to draft portfolios
Get personalized recommendations
Access unlimited tool usage
Sign up for free